| Board of Advisors |
Bill McGlashan is a founding partner of TPG Growth — the growth equity and
smaller buyout investment platform of TPG, the global private investment firm.
With more than $2 billion under management, TPG Growth targets investments
in technology, life sciences, renewables, and consumer companies utilizing growth
equity, public equity, and leveraged buyout structures.
Prior to joining TPG in 2004, Bill McGlashan was the chairman and CEO of Critical
Path (NASDAQ: CPTH). He joined Critical Path in April of 2001 to undertake a
major financial and operational restructuring of the company. Previously, Mr. McGlashan co-founded and served as chief executive officer of Vectis Group, a venture
corporation that capitalized and built companies in emerging markets, in partnership with leading U.S.
technology businesses.
Mr. McGlashan also co-founded and served as president of Pharmanex, Inc., a leading phytopharmaceutical
and dietary supplement company with annual sales of approximately $500 million in 20
countries and significant operations in the People’s Republic of China. The company was sold to NSE (NYSE: NUS) in 1999. Prior to Pharmanex, Mr. McGlashan was a senior associate with Bain Capital and
Information Partners.
Mr. McGlashan earned a BA with honors from Yale University and an MBA from the Stanford Graduate
School of Business. Bill is a member of Young Presidents’ Organization in the San Francisco Barbary
Coast chapter. He serves on the boards of XOJet, David’s Bridal, AgraQuest, SuccessFactors, Elevance,
the Bay Area Discovery Museum, and Backroads.